{
  "step": {
    "id": "oncology.dx.biomarker",
    "label_en": "Tumour biomarker and molecular testing"
  },
  "eu_layer": [
    {
      "id": "eu.cbhc.reimbursement",
      "article": "Art. 7",
      "strength": "binding",
      "summary": "The Member State of affiliation reimburses cross-border healthcare up to the cost it would have paid domestically, if the care is among the patient's entitlements. Gatekeeping conditions (e.g. a GP assessment) may be imposed as for domestic care (Art. 7(7)).",
      "act": {
        "act_id": "celex:32011L0024",
        "title": "Directive 2011/24/EU on the application of patients' rights in cross-border healthcare",
        "short_title": "Directive 2011/24/EU (cross-border care)",
        "url": "https://eur-lex.europa.eu/eli/dir/2011/24/oj",
        "binding": "binding_transposition"
      },
      "regulatory": false
    },
    {
      "id": "eu.hta.jca",
      "article": "Art. 7 and Art. 13",
      "strength": "binding",
      "summary": "Joint clinical assessments of new oncology medicines from 12 January 2025 (and selected high-risk medical devices and IVDs later); Member States give due consideration to JCA reports. Biomarker-defined populations make companion diagnostics part of the PICO.",
      "act": {
        "act_id": "celex:32021R2282",
        "title": "Regulation (EU) 2021/2282 on health technology assessment (HTAR)",
        "short_title": "Reg. 2021/2282 (HTA)",
        "url": "https://eur-lex.europa.eu/eli/reg/2021/2282/oj",
        "binding": "directly_applicable"
      },
      "regulatory": true
    },
    {
      "id": "eu.ivdr.devices",
      "article": "Art. 5, Art. 48, Annex VIII",
      "strength": "binding",
      "summary": "IVDs (FIT, HPV tests, PSA assays, IHC and molecular tests) must be CE-marked; cancer tests and companion diagnostics are generally class C and need a notified body, with EMA or national medicines authority consultation for companion diagnostics.",
      "act": {
        "act_id": "celex:32017R0746",
        "title": "Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR)",
        "short_title": "Reg. 2017/746 (IVDR)",
        "url": "https://eur-lex.europa.eu/eli/reg/2017/746/oj",
        "binding": "directly_applicable"
      },
      "regulatory": true
    },
    {
      "id": "eu.ivdr.inhouse",
      "article": "Art. 5(5) (as amended by Regulation (EU) 2024/1860 for transitional dates)",
      "strength": "binding",
      "summary": "Health institutions may make and use in-house tests (laboratory-developed tests) only under the Art. 5(5) conditions: no transfer to another legal entity, appropriate quality management, documentation, and justification that no equivalent CE-marked device meets the patient group's needs (later application date).",
      "act": {
        "act_id": "celex:32017R0746",
        "title": "Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR)",
        "short_title": "Reg. 2017/746 (IVDR)",
        "url": "https://eur-lex.europa.eu/eli/reg/2017/746/oj",
        "binding": "directly_applicable"
      },
      "regulatory": true
    }
  ],
  "national": [
    {
      "jurisdiction": "DE",
      "measures": [
        {
          "id": "de.dev.mpdg",
          "type": "implementation",
          "article": "MPDG",
          "summary": "Implements MDR and IVDR: competent authorities (BfArM, Länder), sanctions, clinical investigation and performance study procedures.",
          "url": "https://www.gesetze-im-internet.de/mpdg/",
          "verification": "cited_unverified"
        }
      ],
      "extra_layers": [],
      "unmet_eu_demand": [],
      "mitigations": []
    },
    {
      "jurisdiction": "NL",
      "measures": [
        {
          "id": "nl.dev.wmh",
          "type": "implementation",
          "article": "Wet medische hulpmiddelen",
          "summary": "Implements MDR and IVDR; IGJ supervises, incl. in-house test conditions for hospital laboratories.",
          "url": "https://english.igj.nl/medical-technology/new-european-regulations-mdr-and-ivdr/new-regulation-eu-2024-1860",
          "verification": "secondary"
        }
      ],
      "extra_layers": [],
      "unmet_eu_demand": [],
      "mitigations": []
    },
    {
      "jurisdiction": "RO",
      "measures": [
        {
          "id": "ro.dev.anmdmr",
          "type": "implementation",
          "article": "Legea 95/2006 (medical devices title) and ANMDMR rules",
          "summary": "ANMDMR is the competent authority for medical devices and IVDs; national provisions for in-house tests in hospital laboratories not located.",
          "url": "https://www.anm.ro",
          "verification": "needs_research"
        },
        {
          "id": "ro.plan.cancer",
          "type": "implementation",
          "article": "Legea 293/2022 (Planul național)",
          "summary": "Law establishing the National Cancer Prevention and Control Plan: screening, early diagnosis, registry and regional cancer centres; implementation by government decision.",
          "url": "https://www.anm.ro/_/LEGI%20ORDONANTE/Lege%20293-2022.pdf",
          "verification": "verified"
        }
      ],
      "extra_layers": [],
      "unmet_eu_demand": [
        {
          "id": "gap.ro.ivdr.inhouse",
          "gap_type": "unclear",
          "summary": "No national guidance located on how hospital laboratories document in-house tests under IVDR Art. 5(5), which matters for molecular pathology."
        }
      ],
      "mitigations": [
        {
          "id": "mit.ro.ivdr",
          "gap_id": "gap.ro.ivdr.inhouse",
          "kind": "medtech",
          "audience": "laboratories",
          "summary": "Template documentation pack for Art. 5(5) in-house tests, or a CE-marked equivalent offer for common biomarker panels.",
          "reference_measure_id": null
        }
      ]
    }
  ],
  "disclaimer": "MVP research dataset compiled by hand from public legal sources; not legal or medical advice. Each row carries a verification level (verified, secondary, cited_unverified, needs_research); only \"verified\" rows were checked against the official text on the dataset date. Gap findings are \"proposed\" until reviewed."
}